Open AccessEfficacy of entecavir in treating hepatitis B virus-associated membranous nephropathy
Author(s) -
Lifeng Wang,
Bin Xie,
Quan Zheng,
Lixia Xu,
Zhiming Ye
Publication year - 2020
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2020.6762/2019
Subject(s) - medicine , entecavir , membranous nephropathy , virology , hepatitis b virus , gastroenterology , virus , glomerulonephritis , kidney , lamivudine
hepatitis B virus-associated membranous nephropathy (HBV-MN) is the most common pathological type of hepatitis B virus-associated glomerulonephritis. This study evaluated the efficacy of entecavir antiviral therapy for HBV-MN patients due to the intolerable side effects of interferon-alpha and high incidence rate of drug-resistance in lamivudine therapy.